Vendor source
Reviewed 15 Jul 2026
Completeness Strong (64%)
e-CTA
Brainomixe-CTA is a decision support software that uses algorithms, artificial intelligence and data analytics to automatically detect LVO and standardize the assessment of collaterals on CT angiography. e-CTA supports single and multi-phase CTA and fully automates the CTA-CS collateral score supported by a color heat-map representing the difference in collaterals between hemispheres. e-CTA estimates phases of CTA image from automatic arterial input and venous output, and provides visualization of major vessels and the location of any detected LVO.
Supported by 5 papers
General Information
Product name
Company
Modality
Main task
Not specified
Subspeciality
Disease targeted
Regulatory Information
Pathway:
MDD
Class:
Class IIa
Verified by Health AI Register
Pathway:
510(k) cleared
Class:
Class II
Verified by Health AI Register
Other certifications
Not specified
Evidence & Research
Peer-Reviewed Papers
Artificial Intelligence–Based CTA Software for Real-World Detection of Large Vessel Occlusion in Acute Ischemic Stroke
European Neurology · Jul 2026
Real world clinical experience of using Brainomix e-CTA software in a medium size acute National Health Service Trust
British Journal of Radiology · Jan 2025
Automated CT angiography collateral scoring in anterior large vessel occlusion stroke: A multireader study
Interventional Neuroradiology · Jan 2023
Comparison of automated ASPECTS, large vessel occlusion detection and CTP analysis provided by Brainomix and RapidAI in patients with suspected ischaemic stroke
Journal of Stroke and Cerebrovascular Diseases · Aug 2022
Diagnostic accuracy of automated occlusion detection in CT angiography using e-CTA
International Journal of Stroke · Feb 2021
Technical Specifications
Patient population age
Not specified
Input
Input format
Output
Output format
Not specified
Integration
Deployment
Trigger for analysis
Processing time
Not specified
Population
Market Presence
On market since
AI Platforms
Resellers
Not specified
Countries present
Not specified
Paying clinical customers
Not specified
Research/test users
Not specified
Pricing Information
Pricing model
Not specified
Based on
Not specified
Source: Vendor | First published: Feb 18, 2024 | Last updated: Jul 15, 2026